anlotinib
sino biopharmaceuticals,advenchen
['lung', 'sclc', 'anlotinib']
#anlotinib favorable #efficacy outcomes and #safety in pre-treated sclc patients learn more #esmo2022 #esmo22 #lungcancer
#TumoriJournal is an international peer-reviewed journal focused on cancer research and clinical practice owned by @IstTumori Milan, IT